Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 5, Number 1—February 1999


Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases

Larry Zeitlin*, Richard A. Cone*†, and Kevin J. Whaley*†Comments to Author 
Author affiliations: *ReProtect, LLC, Baltimore, Maryland, USA; †The Johns Hopkins University, Baltimore, Maryland, USA

Main Article

Table 3

Preventive vaccines or cures for major sexually transmitted disease pathogens

Pathogen Vaccine Cure DRSa
Chlamydia trachomatis no yes
Haemophilus ducreyi no yes X
Hepatitis B yes no
Herpes simplex 1 and 2 no no X
HIV-1 and 2 no no X
Human papilloma virus (HPV) no yesb
Neisseria gonorrhoeae no yes X
Treponema pallidum no yes
Trichomonas vaginalis no yes X

aDrug-resistant strains reported.
bSurgical removal of HPV-infected tissue is performed.HPV-related cervical cancer identified early has a high cure rate; however, in the United States, for every three new cases, there is approximately one death (117).

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO